Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
The most-read journal articles of 2025 include those on emotional eating, procrastination and links between screentime and depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results